- Home
- TNGX vs BLFS Comparison
TNGX vs BLFS Comparison
Compare TNGX & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- BLFS
- Stock Information
- Founded
- TNGX 2014
- BLFS 1987
- Country
- TNGX United States
- BLFS United States
- Employees
- TNGX 140
- BLFS N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- BLFS Medical/Dental Instruments
- Sector
- TNGX Health Care
- BLFS Health Care
- Exchange
- TNGX Nasdaq
- BLFS Nasdaq
- Market Cap
- TNGX 747.9M
- BLFS 1.1B
- IPO Year
- TNGX N/A
- BLFS 1989
- Fundamental
- Price
- TNGX $6.98
- BLFS $24.54
- Analyst Decision
- TNGX Strong Buy
- BLFS Strong Buy
- Analyst Count
- TNGX 8
- BLFS 6
- Target Price
- TNGX $15.14
- BLFS $26.67
- AVG Volume (30 Days)
- TNGX 1.3M
- BLFS 302.5K
- Earning Date
- TNGX 11-06-2024
- BLFS 11-07-2024
- Dividend Yield
- TNGX N/A
- BLFS N/A
- EPS Growth
- TNGX N/A
- BLFS N/A
- EPS
- TNGX N/A
- BLFS N/A
- Revenue
- TNGX $42,509,000.00
- BLFS $139,959,000.00
- Revenue This Year
- TNGX $18.15
- BLFS N/A
- Revenue Next Year
- TNGX N/A
- BLFS $8.52
- P/E Ratio
- TNGX N/A
- BLFS N/A
- Revenue Growth
- TNGX 26.16
- BLFS N/A
- 52 Week Low
- TNGX $5.15
- BLFS $8.92
- 52 Week High
- TNGX $13.01
- BLFS $26.73
- Technical
- Relative Strength Index (RSI)
- TNGX 33.20
- BLFS 50.42
- Support Level
- TNGX $6.72
- BLFS $23.61
- Resistance Level
- TNGX $7.78
- BLFS $25.63
- Average True Range (ATR)
- TNGX 0.56
- BLFS 1.19
- MACD
- TNGX -0.11
- BLFS -0.04
- Stochastic Oscillator
- TNGX 8.48
- BLFS 47.30
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.